Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
| Tafinlar (S) | dabrafenib | Lungekreft (kombinasjonsbehandling) | 2018 |
|---|
| Taflotan | tafluprost | Glaukom | 2018 |
|---|
|
Tagrisso (S) | osimertinib | Ikke-småcellet lungekreft | 2016 |
|---|
| Tagrisso (S) | osimertinib | Ikke-småcellet lungekreft | 2018 |
|---|
| Taltz (S) | Iksekizumab | Plakkpsoriasis | 2018 |
|---|
| Taltz (S) | Iksekizumab | Psoriasisartritt | 2018 |
|---|
| erlotinib | Ikke-småcellet lungekreft | 2006 |
|---|
| erlotinib | Ikke-småcellet lungekreft, 1. linje | 2012 |
|---|
| oksykodon, nalokson | Sterke smerter (palliativ behandling i livets sluttfase) | 2011 |
|---|
| nilotinib | KML | 2011 |
|---|
| Tasigna | nilotinib | KML, 1. linje | 2013 |
|---|
|
Tasigna | nilotinib | KML, 1. linje | 2016 |
|---|
| Tecentriq (S) | atezolizumab | Ikke-småcellet lungekreft (PD-L1 positiv) | 2018 |
|---|
| Tecentriq (S) | atezolizumab | Ikke-småcellet lungekreft (ikke PD-L1 positiv) | 2018 |
|---|
| Tecfidera (S) | dimetylfumarat | Multippel sklerose | 2014 |
|---|
| filgrastim | Nøytropeni | 2010 |
|---|
| frovatriptan | Migrene | 2006 |
|---|
| Tobi | tobramycin | Cystisk fibrose | 2012 |
|---|
| alitretinoin | Kronisk håndeksem | 2011 |
|---|
| Toctino | alitretinoin | Kronisk håndeksem | 2014 |
|---|
| Toujeo | insulin glargin | Diabetes type 1 | 2015 |
|---|
| Toujeo | insulin glargin | Diabetes type 2 | 2017 |
|---|
| Toviaz | fesoterodin | Inkontinens | 2008 |
|---|
| linagliptin | Diabetes type 2 | 2012 |
|---|
| Trelegy Ellipta | flutikason, umeklidinium, vilanterol | KOLS | 2018 |
|---|
Tresiba
Tresiba | insulin degludec | Diabetes type 1 | 2015
2016 |
|---|
| Trevicta | paliperidonpalmeat | Schizofreni | 2016 |
|---|
| Trimbow | beklometason, formoterol, glykopyrronium | KOLS | 2017 |
|---|
| Truberzi | eluksadolin | IBS-D | 2017 |
|---|
| Trulicity | dulaglutid | Diabetes type 2 | 2015 |
|---|
